Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II Study.

Trial Profile

Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II Study.

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Nov 2014

At a glance

  • Drugs Bevacizumab (Primary) ; Paclitaxel (Primary)
  • Indications Malignant melanoma
  • Focus Therapeutic Use
  • Acronyms AbraxAvast
  • Most Recent Events

    • 13 Jun 2011 Status changed from active, no longer recruiting to completed.
    • 07 Jun 2011 Results were presented at the 47th Annual Meeting of the American Society of Oncology (ASCO-2011).
    • 23 Jun 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top